Investment
Features
FeesSafety
Academy
More
Pluang+

Northland Securities raises Ouster's price target to $60 on strong LiDAR market growth and profitability goals.

Analyst Insights
21 Jul 2026
Andrew Wynn
View Source
Bullish
pluang ai news

Northland Securities has increased its price target for Ouster to $60, reflecting a 55.88% upside from the current price. Ouster, a company specializing in digital LiDAR sensors for autonomous vehicles and robotics, aims to reach EBITDA breakeven with annual revenue growth targets of 30% to 50%. Investor confidence is rising due to the expanding "physical AI" market, including autonomous vehicles and robotics. The stock is currently trading near $39, supported by strong recent growth and market interest in LiDAR technology.

More News

Stocks surge on acquisition news, speculative trading, and defense tech expansion

Stocks surge on acquisition news, speculative trading, and defense tech expansion

Stocks saw notable gains driven by specific events: Cynata Therapeutics surged over 800% due to speculative trading without known corporate news; Utz Brands jumped nearly 89% following a $14.25 per share acquisition offer now under shareholder fairne...

Market News
Bullish
18 minutes ago
Study confirms TLX591-Tx's safety and efficacy in advanced prostate cancer using PSMA-PET imaging for patient selection

Study confirms TLX591-Tx's safety and efficacy in advanced prostate cancer using PSMA-PET imaging for patient selection

Telix Pharmaceuticals published results from the ProstACT SELECT Phase 1 study showing that TLX591-Tx, a targeted radio antibody-drug conjugate therapy for advanced metastatic prostate cancer, is safe and effective when patients are selected using 68...

Company Fundamentals
Bullish
18 minutes ago
Global AI in drug repurposing market to hit $10.56B by 2035, growing at 23.4% CAGR

Global AI in drug repurposing market to hit $10.56B by 2035, growing at 23.4% CAGR

The global AI in drug repurposing market, valued at $1.28 billion in 2025, is projected to reach $10.56 billion by 2035 with a CAGR of 23.4%. This growth is driven by the need to accelerate drug discovery, reduce costs, and address chronic and rare d...

Market News
Bullish
18 minutes ago
Strata Critical Medical schedules Q2 2026 earnings call for August 4 before market open

Strata Critical Medical schedules Q2 2026 earnings call for August 4 before market open

Strata Critical Medical will release its financial results for the second quarter ending June 30, 2026, on August 4 before the market opens. The company will hold a conference call at 8:00 am Eastern Time the same day, hosted by its Co-CEOs, to discu...

Company Fundamentals
Neutral
27 minutes ago
Wintrust Financial posts strong Q2 2026 earnings, raising price target to $170.

Wintrust Financial posts strong Q2 2026 earnings, raising price target to $170.

Wintrust Financial reported strong Q2 2026 earnings of $3.30 per share, beating estimates by 4.76%, with revenue of $741.38 million and record net income of $233.70 million. The company showed robust year-over-year growth, with net income up 20% in t...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App